Abstract:Objective Cytochrome P450 enzymes (CYPs) are capable of catalyzing regio‐ and stereo‐specific oxy functionalization reactions which otherwise are major challenges in organic chemistry. In order to make the best possible use of these biocatalysts it is imperative to understand their specificities. Human CYP21A2 (steroid 21‐hydroxylase) is known as one important enzyme in the biotransformation of progestins into corticosteroids. Humans with a reduced activity of steroid 21‐hydroxylase suffer from congenital adrenal hyperplasia (CAH), that is characterized by reduced production of cortisol. Due to feedback mechanisms of the hypothalamic pituitary adrenal axis, increased concentrations of progestins, but also androgens resulting from alternative metabolic pathways are observed in these patients. As enzymes in steroid biosynthesis are generally considered to show high substrate selectivity a closer investigation on structure requirements of steroid 21‐hydroxylase was conducted. Methods Biotransformation experiments were performed using a fission yeast expressing human CYP21A2 (CAD75) in a whole‐cell biotransformation assay [1] . Progesterone, pregnenolone, and their corresponding 17‐hydroxy analogues were used as substrates. Product formation was monitored by GC‐MS. Molecular docking experiments were performed using GOLD software using the X‐ray structure of CYP21A2 co‐crystallized with progesterone (17, PDB entry 4Y8W [2] ) as protein conformation. Results An investigation on A‐ring requirements yielded that the presence of a 3‐oxo group is a strict prerequisite for a CYP21A2 substrate [1] . In line with these findings the incubation of the endogenous progestins pregnenolone (3β‐hydroxy‐pregn‐5‐en‐20‐one) and 17α‐hydroxypregnenolone (3β,17α‐dihydroxy‐pregn‐5‐en‐20‐one) did not result in successful 21‐hydroxylation, while progesterone (pregn‐4‐ene‐3,20‐dione) and 17‐hydroxyprogesterone (17α‐hydroxy‐pregn‐4‐ene‐3,20‐dione) were hydroxylated at C‐21. Molecular docking experiments supported the structure requirements. Apparently, the interaction of the carbonyl group at C‐3 of the substrate to the side‐chain Arg234 of the enzyme is indispensable. Conclusions The results are opposed to actual scientific view of steroid biosynthesis which for example supposes formation of 21‐hydroxypregnenolone is also catalyzed by CYP21A2 [3] . They also help to understand metabolic pathways of steroids in the human body and may be useful in further synthesis experiments due to the use of enzymes as biocatalysts.

The Human Steroid Hydroxylases CYP1B1 and CYP11B2.

Development of test systems for the discovery of selective human aldosterone synthase (CYP11B2) and 11beta-hydroxylase (CYP11B1) inhibitors. Discovery of a new lead compound for the therapy of congestive heart failure, myocardial fibrosis and hypertension.

Development of test systems for the discovery of selective human aldosterone synthase (CYP11B2) and 11β-hydroxylase (CYP11B1) inhibitors.

CYP11A1 stimulates the hydroxylase activity of CYP11B1 in mitochondria of recombinant yeast in vivo and in vitro

Corticosteroid Biosynthesis Revisited: No Direct Hydroxylation Of Pregnenolone By Steroid 21-Hydroxylase

Corticosteroid Biosynthesis Revisited: Substrate Specificity of Steroid 21-Hydroxylase

The development of a whole-cell based medium throughput screening system for the discovery of human aldosterone synthase (CYP11B2) inhibitors: Old drugs disclose new applications for the therapy of congestive heart failure, myocardial fibrosis and hypertension

Regioselective hydroxylation of steroid hormones by human cytochromes P450

Adrenal Mitochondria and Steroidogenesis: From Individual Proteins to Functional Protein Assemblies

11 beta-hydroxylase activity in recombinant yeast mitochondria. In vivo conversion of 11-deoxycortisol to hydrocortisone

Human steroid and oxysterol 7α-hydroxylase CYP7B1: substrate specificity, azole binding and misfolding of clinically relevant mutants

The metabolism of steroids, toxins and drugs by 11β-hydroxysteroid dehydrogenase 1.

Deletion hybrid genes, due to unequal crossing over between CYP11B1 (11beta-hydroxylase) and CYP11B2(aldosterone synthase) cause steroid 11beta-hydroxylase deficiency and congenital adrenal hyperplasia

Comparative Biochemical Characterization of Mammalian-Derived CYP11A1s with Cholesterol Side-Chain Cleavage Activities

Hydroxylation of CYP11A1-derived products of vitamin D3 metabolism by human and mouse CYP27B1.

Congenital Adrenal Hyperplasia Due to 11-Hydroxylase Deficiency-Compound Heterozygous Mutations of a Prevalent and Two Novel CYP11B1 Mutations.

Inhibitors of 11&Amp;#946;-Hydroxylase (CYP11B1) for Treating Diseases Related to Excess Cortisol

Enzyme-activated inhibitors of steroidal hydroxylases

Overview of human 20 alpha-hydroxysteroid dehydrogenase (AKR1C1): Functions, regulation, and structural insights of inhibitors

Impaired 11β-hydroxysteroid dehydrogenase type 2 activity in kidney disease disrupts 11-oxygenated androgen biosynthesis

Comparison of a Homology Model and the Crystallographic Structure of Human 11Β-Hydroxysteroid Dehydrogenase Type 1 (11βhsd1) in a Structure-Based Identification of Inhibitors